The 8 analysts offering 12-month price forecasts for Esperion Therapeutics Inc have a median target of 7.00, with a high estimate of 22.00 and a low estimate of 2.00. The median estimate represents a +424.34% increase from the last price of 1.34.
The current consensus among 9 polled investment analysts is to Buy stock in Esperion Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.42
Reporting Date Feb 20
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.